Boosting immunotherapy of triple negative breast cancer through the synergy of mild PTT and Fe-loaded organosilica nanoparticles-Reference-Cited by-同舟云学术

Boosting immunotherapy of triple negative breast cancer through the synergy of mild PTT and Fe-loaded organosilica nanoparticles

Published:2022 Issue:41 Volume:10 Page:8490-8501
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Yang Ben¹²,Fu Hui²,Kong Ronghua²,Zheng Gang²,Wang Xihong²,Dong Yang²^ORCID,Yang Zhenlin³⁴

Affiliation:

1. Shandong University Cancer Center, Jinan, Shandong, 250012, China

2. Department of Breast Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China

3. Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China

4. Department of Thyroid and Breast Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, 256603, China

Abstract

Mild photothermal therapy (mild PTT) and Fenton reaction-evoked chemodynamic therapy (CDT) are proposed for effectively boosting the maturation of dendritic cells (DCs) and the sequential antitumor immune response.

Funder

Natural Science Foundation of Shandong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2022/TB/D2TB01424F

Reference58 articles.

1. Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020

2. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

3. Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment